RVMD
RVMD
US76155X1000
Revolution Medicines, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
1.182.369.000 689.524.000
71.5%
Operating Income -1.182.369.000 -689.524.000
71.5%
Pretax Income -1.131.301.000 -600.846.000
88.3%
Net Income Common Stockholders -1.131.301.000 -600.093.000
88.5%
-- --
--
-- --
--
ende